Sterol Carrier Protein-2 (SCP-2) is a protein involved in lipid metabolism, specifically in the intracellular transport and metabolism of cholesterol and fatty acids. SCP-2 facilitates the transfer of lipids between membranes and plays a role in the utilization of fatty acids within the cell. Given the central importance of lipids in various cellular processes, including membrane fluidity and function, energy storage, and signaling, SCP-2 is considered a crucial player in maintaining cellular lipid homeostasis.
Inhibitors of SCP-2 would be molecules engineered to modulate the function, expression, or stability of the SCP-2 protein. Considering SCP-2's role in lipid transport and metabolism, its inhibition could have profound effects on lipid dynamics within the cell. SCP-2 inhibitors might encompass small molecules that bind directly to SCP-2, hindering its lipid-binding or transfer abilities. By obstructing these functions, the intracellular distribution and utilization of lipids could be altered. Another avenue for SCP-2 inhibition might involve molecules that interfere with the post-translational modifications of SCP-2. These modifications can govern its activity, cellular localization, or interactions with other proteins and lipids. Additionally, sophisticated molecular strategies, such as RNA interference or antisense oligonucleotides, might be deployed to modulate SCP-2 expression at the genetic level. Delving into the impacts of SCP-2 inhibition can provide valuable insights into its specific roles in lipid metabolism and transport, enhancing our comprehension of the multifaceted regulatory mechanisms that underpin cellular lipid dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Statins inhibit cholesterol synthesis and might indirectly affect SCP-2 expression by altering cellular lipid homeostasis. | ||||||
DCC | 538-75-0 | sc-239713 sc-239713A | 25 g 100 g | $72.00 $208.00 | 3 | |
DCCD has been shown to inhibit SCP-2's lipid transfer activity, which could indirectly influence its expression. | ||||||
Probucol | 23288-49-5 | sc-203666 sc-203666A | 100 mg 1 g | $79.00 $166.00 | 5 | |
Probucol reduces plasma cholesterol levels. Its influence on cholesterol metabolism might indirectly modulate SCP-2 expression. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $27.00 $35.00 | 20 | |
Neomycin affects lipid absorption and metabolism, potentially influencing SCP-2 expression. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
By affecting lipid metabolism, niacin might indirectly influence SCP-2 expression. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Clofibrate, a lipid-lowering drug, might indirectly modulate SCP-2 levels by affecting lipid homeostasis. | ||||||
CHOLESTYRAMINE RESIN | 11041-12-6 | sc-507509 | 5 g | $210.00 | ||
By sequestering bile acids, cholestyramine affects cholesterol metabolism which could influence SCP-2 expression. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
As a lipid-regulating drug, gemfibrozil might influence SCP-2 expression by modulating lipid homeostasis. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Excess free fatty acids like oleic acid might alter SCP-2 expression by influencing lipid metabolism. | ||||||